Mammoth Biosciences, co-founded by Nobel Laureate Jennifer Doudna, is the industry’s first CRISPR platform company. It has already delivered a breakthrough Covid test and has inked partnerships for novel CRISPR diagnostics, therapeutics and biomanufacturing with leading healthcare companies. NotCo is combining artificial intelligence and deep science to re-invent the food industry, starting with a milk alternative product with many more to come. Hear about the founder journey from these breakout companies and tips for scaling your business.
Arvind Gupta — Partner, Mayfield Fund
Arvind Gupta co-leads Mayfield’s Engineering Biology practice whose mission is to invest in science based companies that could change history. Ranging from reinventing our food system to stopping climate change to novel therapeutics, Arvind was the first investor in breakout companies such as Geltor, Synthex, Prime Roots, NotCo, Prellis, New Culture, DNA Lite, Catalog, Prellis and Memphis Meats. As Founder of IndieBio, Arvind redefined the pace and possibilities of early stage biotech, investing in over 136 companies in five years, defining human and planetary health, and growing the IndieBio portfolio into billions of dollars in value. Under his leadership, IndieBio expanded to New York and grew to fifteen investment professionals with a world renowned adjunct partner board. He now serves as Venture Advisor at IndieBio. Prior to founding IndieBio, Arvind was Design Director at IDEO in Shanghai where he earned numerous international design awards and presented his work at the San Francisco Museum of Modern Art. He was also a BASE jumper and big wall climber and now fights professional grappling.
Trevor Martin — Co-Founder & CEO, Mammoth Biosciences
Dr. Trevor Martin co-founded Mammoth Biosciences with the mission to enable the next generation of CRISPR-based synthetic biology products across therapeutics and diagnostics. Areas of focus include a novel class of affordable, effective, and rapid CRISPR-enabled molecular diagnostics that allow individuals worldwide to better understand their health and novel families of nano-sized CRISPR proteins including Cas14 and CasPhi that can enable in-vivo editing and permanent genetic cures. Trevor earned his BA from Princeton University and his Ph.D. in Biology from Stanford. His scientific work has been featured in outlets including FiveThirtyEight and The Atlantic. He is the featured healthcare honoree on the Forbes 30 Under 30 list, is on Fortune’s 40 Under 40 list, and is a Malaria No More “10 to END” innovator.
Matias Muchnick — Founder & CEO, NotCo
Matias is the CEO and Founder at NotCo, the fastest growing food-tech company in LATAM that recently launched NotMilk in the US market nationwide in Wholefoods with outstanding momentum. Having raised $235M USD from investors like Jeff Bezos, Quest Love, Roger Federer, Tiger Management, L-Catterton, Kaszek, 3G Venture arm The Craftory, among others NotCo has become the first Chilean unicorn disrupting the global industry. Matias is a Finance major with postgraduate studies at HBS, UC Berkeley, and Stanford. He worked at JP Morgan Chase in Hong Kong. He is now leading NotCo with a base in New York City.